InVitae (NVTA) Tops Q4 EPS by 4c

InVitae (NYSE: NVTA) reported Q4 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $9.2 million versus the consensus estimate of $8.82 million.

GUIDANCE:

InVitae sees Q1 2017 revenue of $55-65 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
• Tesla to launch Cybercab in Austin this month - report